Results 171 to 180 of about 90,864 (336)
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista +3 more
wiley +1 more source
Chun-Nan Yeh,1 Feng-Jen Hsieh,1 Kun-Chun Chiang,1 Jen-Shi Chen,2 Ta-Sen Yeh,1 Yi-Yin Jan,1 Miin-Fu Chen1 1Department of General Surgery, 2Department of Medical Oncology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan Background ...
Yeh CN +6 more
doaj
Synthesis of Ribosomes in the Liver after Partial Hepatectomy
Irving Lieberman, Patricia M. Kane
openalex +1 more source
ABSTRACT Background The Wnt/β‐catenin signaling pathway and microvascular invasion (MVI) are associated with the prognosis of hepatocellular carcinoma (HCC). Purpose To evaluate the Wnt/β‐catenin pathway and MVI states using preoperative MR elastography (MRE). Study Type Prospective.
Huanhuan Chong +9 more
wiley +1 more source
Right Hepatectomy for Hamartoma in an Eleven-Month-Old Infant
S Alpert +3 more
openalex +2 more sources
Rat Liver Regeneration After 90% Partial Hepatectomy [PDF]
Johannes Gaub, Johan Iversen
openalex +1 more source
ABSTRACT Background Normothermic regional perfusion (NRP) is gaining rapid popularity in adult donation after circulatory death (DCD) to increase organ utilization and improve outcomes. However, literature is lacking for the pediatric population. We therefore present the youngest DCD donor in the United States from whom a liver was recovered with NRP ...
Raphaël M. J. Fischer +5 more
wiley +1 more source
Degradation and resynthesis of gap junction protein in plasma membranes of regenerating liver after partial hepatectomy or cholestasis [PDF]
Otto Traub +2 more
openalex +1 more source
Measuring success in hepatectomy
Kashif, Zain +2 more
openaire +2 more sources
Liver‐directed therapies for colorectal liver metastases
Abstract Colorectal cancer is the third most common cancer diagnosed in the United States, with an anticipated 53,000 deaths from this disease in 2025. Greater than one in five patients will present with synchronous colorectal liver metastases (CRLMs), and 25%–30% will develop CRLMs during the course of the disease.
Andrew D. Folkerts +2 more
wiley +1 more source

